KALA BIO
KALA
22 hedge funds and large institutions have $294K invested in KALA BIO in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
10% more funds holding
Funds holding: 20 → 22 (+2)
40.46% less ownership
Funds ownership: 40.46% → 0% (-40%)
59% less capital inflows, than outflows
Capital inflows: $502K | Capital outflows: $1.23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$159K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$95.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.4K |
| 4 |
GSA Capital Partners
London,
United Kingdom
|
+$35.5K |
| 5 |
Virtu Financial
New York
|
+$27.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$1M |
| 2 |
Woodline Partners
San Francisco,
California
|
-$125K |
| 3 |
Jane Street
New York
|
-$45.7K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$15.7K |
| 5 |
Two Sigma Investments
New York
|
-$15K |
KALA Hedge Fund Activity: Q1 2026 in Review
22 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2026, worth a combined $294K — down 81% from $1.58M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new KALA positions and 7 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $159K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1M sold.
- 22 institutional investors held KALA BIO (KALA) as of Q1 2026, up from 20 in Q4 2025.
- Funds reported $294K of KALA BIO stock for Q1 2026, down 81% quarter-over-quarter.
- 10 funds opened new KALA BIO positions in Q1 2026 and 7 closed out, a net change of +3 holders.
- The largest KALA BIO buyer in Q1 2026 was Renaissance Technologies, an estimated $159K added.
- The largest KALA BIO seller in Q1 2026 was Baker Bros. Advisors, an estimated $1M sold.
Based on aggregated 13F filings for Q1 2026.